Other
SEKISUI MEDICAL CO., LTD, announces launching the products of XenoTech, LLC
July, 2009
We are pleased to inform you that effective 1st July, 2009, SEKISUI MEDICAL CO., LTD.,will be the new, exclusive distributor for XenoTech LLC in Japan.
XenoTech, a company located in Lenexa, Kansas, U.S.A. and owned by the SEKISUI CHEMICAL GROUP is an established provider of in vitro products for drug metabolism-related research and in vitro contract services for drug candidate evaluation.
XenoTech’s product selection includes a wide range of high quality standard cell-based systems derived from human and animal tissue which are widely used by customers throughout the US, Europe as well as Japan.
Its contract services, which include a range of drug metabolism and drug-drug interaction studies, are also widely adopted throughout the global pharmaceutical and biotechnology industry.
Also, Dr. Parkinson, the CEO/CSO of XenoTech, is well renowned for his scientific achievements in drug metabolism-related
research. He has served on NIH study section and is a consultant to several pharmaceutical companies and the FDA.
Date:
July 1st, 2009
Product:
Subcellular product of liver, lung, intestine and kidney
Hepatocyte
Media etc.
For further information, contact:
Sekisui Medical Co., Ltd.,
ADME & Tox. Research Institute, Sales Group
Phone 03-3272-1032
